|
|
Profile
|
Delegates :
Shin Yoshida |
|
Incorporated :
January 16 , 2024 |
Paid in Capital :
101 Million yen |
Employees :
人 |
Address :
Kouraku 2Choume 3-21, Bunkyou-ku TOKYO
〒112-0004
|
TEL/FAX :
/ |
URL：
https://www.gelcoatbio.com/en |
Attachment :
|
Mission/Background :
Gel Coat Biomaterials, Inc. was started based on the hydrogel technology developed by Professor Madoka Takai of the Graduate School of Engineering, The University of Tokyo. This hydrogel has the characteristics of an amoeba that can freely take in various molecules and change its shape. When the amoeba hydrogel encapsulates a biomaterial, the biomaterial is stabilized and exhibits excellent functionality. Our amoeba hydrogel stabilization technology enables the use of biomaterials in environments, applications, and durations that were previously unavailable, thereby providing new value to biomaterials. We will continue to create innovations as a group of experts in life science, bioengineering, polymer science, device development, and medical devices. We will also take on the challenge of solving social issues through active collaboration and open innovation. |
|
Technology & Business
|
Enzymes, cells, organs, and other biomaterials have excellent functions, but their instability limits the environments, applications, and timeframes in which they can be used.
Professor Madoka Takai, Graduate School of Engineering, The University of Tokyo, has long studied zwitterionic polymers, which are biocompatible materials. The protective layer of water formed on the substrate surface by coating the substrate with this hydrophilic zwitterionic polymer inhibits adsorption of cell and protein to the surface of the substrate, thus stabilizing the bio-implantable device or artificial organ for a long time.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Enzymatic Synthesis Process of API
|
Discovery
|
Amoeba Hydrogel of Gel Coat Biomaterials, Inc. protects enzymes to increase their stability.
|
|
Research and development services to improve the stability of biopharmaceuticals against degrading enzymes.
|
Discovery
|
Amoeba Hydrogel improves the anti-proteinase stability of biopharmaceuticals.
|
|
Research and development services to improve the stability of enzymes for bio-synthesis and bio-decomposition.
|
Discovery
|
Amoeba Hydrogel accelerates the decomposition of plastic waste by supporting the enzymatic reaction.
|
|
New Therapeutics with Bio Power Generator
|
Discovery
|
The realization of new treatments, such as deep brain stimulation (DBS) for treatment-resistant depression.
|
|
|
|
|
|
|
Hot news
|
・Limited-time Offer: Samples of our proprietary hydrogels are available. We provide support for setting up studies focused on enzyme and nucleic acid stabilization using our hydrogels.
・We look forward to welcoming you at our booth at BIO International Convention 2025.
|
|
Alliance strategy
|
Leverage our proprietary biocompatible hydrogels to stabilize enzymes and biomolecules.
・We offer solutions for stabilizing enzymes & their processes. Invite companies working on or interested in enzyme-based product development and environmental impact reduction to connect with us.
・Improve biopharmaceutical stability. We provide technology to prevent the in vivo degradation of enzymes, nucleic acids, and antibodies. Seeking collaboration with who developing enzyme/nucleic acid therapies.
|
|
|